Relevance of MIC-1 in the Era of PSA as a Serum Based Predictor of Prostate Cancer: A Critical Evaluation
Abstract To reduce the ambiguity of contradictory observations in different studies regarding the expression level of Macrophage Inhibitory Cytokine-1 (MIC-1) in serum in prostate cancer (PC), benign prostatic hyperplasia (BPH) and healthy controls (HC), we designed this double-blind study. The stud...
Guardado en:
Autores principales: | , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3e65acf04b32411595ca1468f35a97f2 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:3e65acf04b32411595ca1468f35a97f2 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:3e65acf04b32411595ca1468f35a97f22021-12-02T15:04:53ZRelevance of MIC-1 in the Era of PSA as a Serum Based Predictor of Prostate Cancer: A Critical Evaluation10.1038/s41598-017-17207-22045-2322https://doaj.org/article/3e65acf04b32411595ca1468f35a97f22017-12-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-17207-2https://doaj.org/toc/2045-2322Abstract To reduce the ambiguity of contradictory observations in different studies regarding the expression level of Macrophage Inhibitory Cytokine-1 (MIC-1) in serum in prostate cancer (PC), benign prostatic hyperplasia (BPH) and healthy controls (HC), we designed this double-blind study. The study comprises 240 sera from PC, BPH and HC subjects. The expression level of MIC-1 in PC, BPH and HC were appraised using Western blot (WB) and ELISA based approach. WB and ELISA appraisal reveals that the expression level of MIC-1 is significantly higher in PC than in HC or BPH subjects. Regression analysis revealed a significant correlation between MIC-1 vs. PSA (r = 0.09; p < 0.001) and MIC-1 vs. GS (r = 0.7; p < 0.001). ROC analysis using discriminant predicted probability revealed that the MIC-1 was better than PSA. Moreover, the combination of MIC-1 and PSA was allowing 99.1% AUC for the differentiation of BPH + PC from HC, 97.9% AUC for differentiation of BPH from HC, 98.6% AUC for differentiation of PC from HC, and 96.7% AUC for the differentiation of PC from BPH. The augmented expression of MIC-1 in PC compared to BPH and HC subjects is in concurrent of the over-expression of MIC-1 in PC reports and confiscates the contradictory findings of other studies.Navneeta BansalDeepak KumarAshish GuptaDeepak ChandraSatya Narain SankhwarAnil MandhaniNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-8 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Navneeta Bansal Deepak Kumar Ashish Gupta Deepak Chandra Satya Narain Sankhwar Anil Mandhani Relevance of MIC-1 in the Era of PSA as a Serum Based Predictor of Prostate Cancer: A Critical Evaluation |
description |
Abstract To reduce the ambiguity of contradictory observations in different studies regarding the expression level of Macrophage Inhibitory Cytokine-1 (MIC-1) in serum in prostate cancer (PC), benign prostatic hyperplasia (BPH) and healthy controls (HC), we designed this double-blind study. The study comprises 240 sera from PC, BPH and HC subjects. The expression level of MIC-1 in PC, BPH and HC were appraised using Western blot (WB) and ELISA based approach. WB and ELISA appraisal reveals that the expression level of MIC-1 is significantly higher in PC than in HC or BPH subjects. Regression analysis revealed a significant correlation between MIC-1 vs. PSA (r = 0.09; p < 0.001) and MIC-1 vs. GS (r = 0.7; p < 0.001). ROC analysis using discriminant predicted probability revealed that the MIC-1 was better than PSA. Moreover, the combination of MIC-1 and PSA was allowing 99.1% AUC for the differentiation of BPH + PC from HC, 97.9% AUC for differentiation of BPH from HC, 98.6% AUC for differentiation of PC from HC, and 96.7% AUC for the differentiation of PC from BPH. The augmented expression of MIC-1 in PC compared to BPH and HC subjects is in concurrent of the over-expression of MIC-1 in PC reports and confiscates the contradictory findings of other studies. |
format |
article |
author |
Navneeta Bansal Deepak Kumar Ashish Gupta Deepak Chandra Satya Narain Sankhwar Anil Mandhani |
author_facet |
Navneeta Bansal Deepak Kumar Ashish Gupta Deepak Chandra Satya Narain Sankhwar Anil Mandhani |
author_sort |
Navneeta Bansal |
title |
Relevance of MIC-1 in the Era of PSA as a Serum Based Predictor of Prostate Cancer: A Critical Evaluation |
title_short |
Relevance of MIC-1 in the Era of PSA as a Serum Based Predictor of Prostate Cancer: A Critical Evaluation |
title_full |
Relevance of MIC-1 in the Era of PSA as a Serum Based Predictor of Prostate Cancer: A Critical Evaluation |
title_fullStr |
Relevance of MIC-1 in the Era of PSA as a Serum Based Predictor of Prostate Cancer: A Critical Evaluation |
title_full_unstemmed |
Relevance of MIC-1 in the Era of PSA as a Serum Based Predictor of Prostate Cancer: A Critical Evaluation |
title_sort |
relevance of mic-1 in the era of psa as a serum based predictor of prostate cancer: a critical evaluation |
publisher |
Nature Portfolio |
publishDate |
2017 |
url |
https://doaj.org/article/3e65acf04b32411595ca1468f35a97f2 |
work_keys_str_mv |
AT navneetabansal relevanceofmic1intheeraofpsaasaserumbasedpredictorofprostatecanceracriticalevaluation AT deepakkumar relevanceofmic1intheeraofpsaasaserumbasedpredictorofprostatecanceracriticalevaluation AT ashishgupta relevanceofmic1intheeraofpsaasaserumbasedpredictorofprostatecanceracriticalevaluation AT deepakchandra relevanceofmic1intheeraofpsaasaserumbasedpredictorofprostatecanceracriticalevaluation AT satyanarainsankhwar relevanceofmic1intheeraofpsaasaserumbasedpredictorofprostatecanceracriticalevaluation AT anilmandhani relevanceofmic1intheeraofpsaasaserumbasedpredictorofprostatecanceracriticalevaluation |
_version_ |
1718389010446942208 |